About
Periodic safety update report single assessments (PSUSAs) are single assessments of related periodic safety update reports (PSURs) for active substances contained in medicines authorised in the European Union (EU). A PSUR is a pharmacovigilance report submitted regularly by a marketing-authorisation holder at defined time points following a medicine's authorisation.
Key facts
- Active substance(s) in scope of the PSUSA procedure
- Ciclosporin (systemic use)
- Procedure number
- PSUSA/00000745/202112
- Regulatory outcome
- Variation
Documents
Ciclosporin (systemic use) : List of nationally authorised medicinal products - PSUSA/00000745/202112
English (EN) (298.42 KB - PDF)
Ciclosporin (systemic use) : CMDh Scientific conclusions and grounds for variation, amendments to the Product Information and timetable for the implementation - PSUSA/00000745/202112
English (EN) (141.2 KB - PDF)
български (BG) (161.39 KB - PDF)
español (ES) (124.42 KB - PDF)
čeština (CS) (178.06 KB - PDF)
dansk (DA) (127.64 KB - PDF)
Deutsch (DE) (130.82 KB - PDF)
eesti keel (ET) (121.74 KB - PDF)
ελληνικά (EL) (135.03 KB - PDF)
français (FR) (124.88 KB - PDF)
hrvatski (HR) (159.49 KB - PDF)
íslenska (IS) (127.97 KB - PDF)
Gaeilge (GA) (122.87 KB - PDF)
italiano (IT) (128.47 KB - PDF)
latviešu valoda (LV) (171 KB - PDF)
lietuvių kalba (LT) (170.85 KB - PDF)
magyar (HU) (156.8 KB - PDF)
Malti (MT) (199.61 KB - PDF)
Nederlands (NL) (126.9 KB - PDF)
norsk (NO) (119.85 KB - PDF)
polski (PL) (148.19 KB - PDF)
português (PT) (125.95 KB - PDF)
română (RO) (171.96 KB - PDF)
slovenčina (SK) (164.5 KB - PDF)
slovenščina (SL) (170.1 KB - PDF)
Suomi (FI) (120.45 KB - PDF)
svenska (SV) (124.11 KB - PDF)